Live Breaking News & Updates on Biodrg

Stay informed with the latest breaking news from Biodrg on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biodrg and stay connected to the pulse of your community

Exclusive: MoonLake Immunotherapeutics explores sale-sources

MoonLake Immunotherapeutics , a developer of an antibody-derived treatment for inflammatory skin conditions, is exploring a sale, according to people familiar with the matter.

Switzerland , New-york , United-states , David-carnevali , Moonlake-immunotherapeutics , Merck-kga , Abbvie-humira , Josie-kao , Abbvie-inc , Prometheus-biosciences-inc , Merck-co , Nasdaq

U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 mln

An influential U.S. drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals /CRISPR Therapeutics and bluebird bio to as much as $2.05 mln, saying the new price can be cost effective to treat sickle cell disease.

United-states , Bengaluru , Karnataka , India , Bhanvi-satija , Vertex-pharmaceuticals , Institute-for-clinical , Reuters , Thomson-reuters-trust-principles , Economic-review , David-rind , Biomarin-pharmaceutical

US govt tells vaccine makers to price updated COVID shots reasonably

COVID vaccine makers should price their updated shots for the fall at a reasonable rate that would reflect the benefits they received through government investments, the U.S. Department of Health and Human Services (HHS) said on Thursday.

United-states , Bengaluru , Karnataka , India , Americans , Shinjini-ganguli , Shailesh-kuber , Bhanvi-satija , Pfizer , Access-program , Drug-administration , Reuters

Mark Cuban's online pharmacy set to launch Humira biosimilar

Mark Cuban Cost Plus Drugs, an online pharmacy launched by the billionaire to sell drugs directly to customers at low prices, should soon begin selling Coherus BioSciences's biosimilar version of AbbVie Inc's blockbuster rheumatoid arthritis drug Humira, Cuban said on Wednesday.

Cuba , Cuban , David-holmes , Coherus-biosciences , Abbvie-inc , Thomson-reuters-trust-principles , Boehringer-ingelheim , Reuters , Cuban-cost-plus-drugs , Plus-drugs , Cost-plus-drugs , Michael-erman

Clene's ALS drug shows reduction in disease indicator levels in trial

Clene said on Thursday its experimental amyotrophic lateral sclerosis (ALS) drug showed reduction in levels of an indicator believed to be tied with the disease progression in a mid-stage trial.

Bengaluru , Karnataka , India , Krishna-chandra-eluri , Raghav-mahobe , Lou-gehrig , Reuters , Thomson-reuters-trust-principles , Drug-administration , Krishna-chandra , Thomson-reuters-trust , Rsbi-regulatory-oversight

BioNTech faces first German lawsuit over alleged COVID vaccine side effects

BioNTech will go to court on Monday to defend itself against a lawsuit from a German woman who is seeking damages for alleged side effects of its COVID-19 vaccine, the first of potentially hundreds of cases in the country.

Germany , Norway , Milan , Lombardia , Italy , London , City-of , United-kingdom , Hamburg , Iceland , Liechtenstein , United-states

Biden administration near deal to preserve preventive care coverage, for now

A mandate that U.S. health insurers cover preventive care like cancer screenings and HIV-preventing medication at no extra cost to patients could remain in place while the Biden administration appeals a court order striking it down, following a tentative agreement announced on Friday.

New-york , United-states , Texas , Fort-worth , Reed-oconnor , Brendan-pierson , Alexia-garamfalvi , Us-circuit-court , Reuters , Thomson-reuters-trust-principles , Human-services , Us-senate

UK to explore wider access to obesity drugs in $50 million pilot

The United Kingdom will explore ways to make obesity drugs more accessible to people outside hospital settings and cut NHS waiting lists in a new 40 million pound ($50 million) two-year pilot programme, the government announced on Wednesday.

Bengaluru , Karnataka , India , United-kingdom , Sunak , Gujarat , British , Semaglutide-wegovy , Reuters , Thomson-reuters-trust-principles , National-health-service , National-institute-for-health

BioNTech says drug from OncoC4 partnership shows promise in mid-stage trial

BioNTech said on Friday that a new cancer immunotherapy candidate that it is working on with U.S. partner OncoC4 Inc was shown to shrink tumours in close to 30% of participants in a mid-stage lung cancer trial.

Friederike-heine , Ludwig-burger , Reuters , Thomson-reuters-trust-principles , Merck-co-mrkn-keytruda , Thomson-reuters-trust , Rsbi-regulatory-oversight , Rhpi-drug-device-trials , Rhpi-regulatory , Biodrg , Cmpny , Cncer

US Supreme Court spurns ex-Shkreli lawyer Greebel's challenge to prosecutors

The U.S. Supreme Court on Tuesday declined to hear a bid by a New York lawyer to restrict how much money federal prosecutors can take from his 401(k) retirement accounts to compensate fraud victims after he was convicted in a scheme involving former pharmaceutical executive Martin Shkreli.

United-states , New-york , Washington , American , Martin-shkreli , Katten-muchin-rosenman , Leigh-jones , Akiva-shapiro , Mike-scarcella , Evan-greebel , Thomson-reuters-trust-principles , Us-circuit-court